Investigación / Grupos de investigación

Grupo  27

Farmacia Hospitalaria y Farmacogenómica

Publicaciones (402)

  • Villanueva-Bueno, C; Montecatine-Alonso, E; Jimenez-Parrilla, F; Fernandez-Llamazares, CM; Manrique-Rodriguez, S; Zamora-Flores, E; Dolz, E; Fernandez-Polo, A; Catillo-Salinas, F; Comunas, J; Gallego-Fernandez, C; Gonzalez-Lopez, M; Calvo, MTGT; Gazquez-Perez, R; del Vayo-Benito, CA; Gil-Navarro, MV; Paediat Antimicrobial Defined Dail.

    Antimicrobial defined daily dose in neonatal population

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2022; 40(2): 59-65 Nº de citas: 5 [doi:10.1016/j.eimc.2021.05.007]

  • Vicente-Valor, J; Garcia-Gonzalez, X; Ibanez-Garcia, S; Duran-Garcia, ME; de Lorenzo-Pinto, A; Rodriguez-Gonzalez, C; Mendez-Fernandez, I; Percovich-Hualpa, JC; Herranz-Alonso, A; Sanjurjo-Saez, M.

    PCSK9 inhibitors revisited: Effectiveness and safety of PCSK9 inhibitors in a real-life Spanish cohort

    BIOMEDICINE & PHARMACOTHERAPY. 2022; 146: 112519-112519 Nº de citas: 10 [doi:10.1016/j.biopha.2021.112519]

  • Enriquez-Gomez, A; Ortega-Navarro, C; Fernandez-Cordon, C; Diez-Villanueva, P; Martinez-Selles, M; de Lorenzo-Pinto, A; de Miguel-Yanes, JM.

    Comparison of a polypharmacy-based scale with Charlson comorbidity index to predict 6-month mortality in chronic complex patients after an ED visit

    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2022; 88(4): 1795-1803 Nº de citas: 2 [doi:10.1111/bcp.15096]

  • Gil-Manso, S; Blanco, IM; Lopez-Esteban, R; Carbonell, D; Lopez-Fernandez, LA; West, L; Correa-Rocha, R; Pion, M.

    Comprehensive Flow Cytometry Profiling of the Immune System in COVID-19 Convalescent Individuals

    Frontiers in Immunology. 2022; 12: 793142-793142 Nº de citas: 10 [doi:10.3389/fimmu.2021.793142]

  • Villanueva-Bueno, C; Escudero-Vilaplana, V; Collado-Borrell, R; Gimenez-Manzorro, A; Ribed, A; Marzal-Alfaro, B; Revuelta-Herrero, JL; Gonzalez-Haba, E; Herranz, A; Sanjurjo, M.

    Medication guide for the perioperative management of oral antineoplastic agents in cancer patients

    EXPERT OPINION ON DRUG SAFETY. 2022; 21(1): 107-119 Nº de citas: 4 [doi:10.1080/14740338.2021.1965990]

  • Martinez, CLC; Jimenez, RMR; Vazquez-Lopez, C; Perez-Cordon, L; Hidalgo, SV; Jose, PB.

    Recommendations for using oral antineoplastic and immunomodulating agents in oncohematology by enteral tube administration

    NUTRICION HOSPITALARIA. 2022; 39(1): 171-201 Nº de citas: 5 [doi:10.20960/nh.03736]

  • Vicente-Valor, J; Escudero-Vilaplana, V; Collado-Borrell, R; Perez-Ramirez, S; Villanueva-Bueno, C; Narrillos-Moraza, A; Garcia-Sanchez, S; Beamud-Cortes, M; Herranz, A; Sanjurjo, M.

    Potential and real drug interactions in patients treated with abiraterone or enzalutamide in clinical practice

    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. 2022; 17(12): 1467-1473 Nº de citas: 10 [doi:10.1080/17425255.2021.2027908]

  • Gomez-Centurion, I; Oarbeascoa, G; Garcia, MC; Fresnena, MCL; Carreno, MJM; Vilaplana, VE; Gonzalez-Haba, E; Bailen, R; Dorado, N; Juarez, LM; Macias, GR; Lopez, PF; Encinas, C; Bastos-Oreiro, M; Anguita, J; Sanjurjo, M; Diez-Martin, JL; Kwon, M.

    Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility

    INTERNATIONAL JOURNAL OF HEMATOLOGY. 2022; 115(1): 61-68 Nº de citas: 11 [doi:10.1007/s12185-021-03219-2]

  • Soria-Chacartegui, P; Villapalos-Garcia, G; Lopez-Fernandez, LA; Navares-Gomez, M; Mejia-Abril, G; Abad-Santos, F; Zubiaur, P.

    Clinical Relevance of Novel Polymorphisms in the Dihydropyrimidine Dehydrogenase (DPYD) Gene in Patients with Severe Fluoropyrimidine Toxicity: A Spanish Case-Control Study

    Pharmaceutics. 2021; 13(12): Nº de citas: 9 [doi:10.3390/pharmaceutics13122036]

  • GARCÍA, X.; SALVADOR, S..

    Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?

    Journal Of Personalized Medicine. 2021; : [doi:https://doi.org/10.3390/jpm11111180]

  • Morillo Verdugo R; Calvin Lamas M; Delgado Latorre ATJ; Ferrando Piqueres R; Fernández-Llamazares CM; Negro Vega E; Tortajada Goitia B.

    Development of the Q-PEX standard for quality certification of pharmaceutical care for outpatients of Pharmacy services

    Journal Of Healthcare Quality Research. 2021; 36(6): 324-332 Nº de citas: 6 [doi:10.1016/j.jhqr.2021.03.010]

  • García-González X; Salvador-Martín S.

    Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?

    Journal Of Personalized Medicine. 2021; 11(11): Nº de citas: 4 [doi:10.3390/jpm11111180]

  • Salvador-Martin, S; Melgarejo-Ortuno, A; Lopez-Fernandez, LA.

    Biomarkers for Optimization and Personalization of Anti-TNFs in Pediatric Inflammatory Bowel Disease

    Pharmaceutics. 2021; 13(11): Nº de citas: 4 [doi:10.3390/pharmaceutics13111786]

  • SALVADOR, S.; MELGAREJO, A.; LOPEZ, L..

    Biomarkers for Optimization and Personalization of Anti-TNFs in Pediatric Inflammatory Bowel Disease

    Pharmaceutics. 2021; 13(11): [doi:https://doi.org/10.3390/pharmaceutics13111786]

  • GIL, S.; CARBONELL, D.; LOPEZ, L.; MIGUENS, I.; ALONSO, R.; BUÑO, I.; Muñoz, P.; Ochando Cano, Jordi; PION, M.; CORREA, R..

    Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days

    Frontiers in Immunology. 2021; 12: 726960-726960 Nº de citas: 18 [doi:10.3389/fimmu.2021.726960]

  • Amor-Garcia, MA; Fernandez-Llamazares, CM; Manrique-Rodriguez, S; Narrillos-Moraza, A; Garcia-Morin, M; Huerta-Aragones, J; Sanjurjo-Saez, M.

    Bromocriptine for the treatment of postoperative cerebellar mutism syndrome in pediatric patients: Three case reports

    JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2021; 27(7): 1753-1757 Nº de citas: 10 [doi:10.1177/1078155220982046]

  • Nieto-Gonzalez, JC; Trives-Folguera, L; Melgarejo-Ortuno, A; Ais, A; Serrano-Benavente, B; Sanjurjo, M; Alvaro-Gracia, JM; Saez, IM.

    Persistence and adherence to biologic therapies in juvenile idiopathic arthritis

    Scientific Reports. 2021; 11(1): 16195-16195 Nº de citas: 4 [doi:10.1038/s41598-021-95252-8]

  • Souza-Neto, FV; Jimenez-Gonzalez, S; Delgado-Valero, B; Jurado-Lopez, R; Genty, M; Romero-Miranda, A; Rodriguez, C; Nieto, ML; Martinez-Martinez, E; Cachofeiro, V.

    The Interplay of Mitochondrial Oxidative Stress and Endoplasmic Reticulum Stress in Cardiovascular Fibrosis in Obese Rats

    Antioxidants. 2021; 10(8): Nº de citas: 28 [doi:10.3390/antiox10081274]